Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases.
Despite the successes provided by vaccination, many challenges still exist with respect to controlling new and re-emerging infectious diseases. Innovative vaccine platforms composed of adaptable adjuvants able to appropriately modulate immune responses, induce long-lived immunity in a single dose, a...
Guardado en:
Autores principales: | Bret D Ulery, Devender Kumar, Amanda E Ramer-Tait, Dennis W Metzger, Michael J Wannemuehler, Balaji Narasimhan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aca5fd4e39604ce3940a2e932b897511 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery
por: Petersen LK, et al.
Publicado: (2013) -
Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8+ T Cell Memory and Delayed Tumor Progression
por: Darling R, et al.
Publicado: (2020) -
Cellular Responses in the Respiratory Tract Following Intranasal administration of Peste des petits Ruminant Vaccine in Goats
por: Ezeasor,C. V, et al.
Publicado: (2013) -
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Jasmina M. Luczo, et al.
Publicado: (2021) -
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
por: Bryce M. Warner, et al.
Publicado: (2021)